aspirin and 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid

aspirin has been researched along with 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guth, BD; Müller, TH1
Arrebola, MM; De La Cruz, JP; Escalante, R; Guerrero, A; Sánchez de La Cuesta, F; Villalobos, MA1

Other Studies

2 other study(ies) available for aspirin and 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid

ArticleYear
DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Basic research in cardiology, 1997, Volume: 92, Issue:3

    Topics: Animals; Aspirin; Biphenyl Compounds; Chlorobenzenes; Coronary Thrombosis; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Heptanoic Acids; Male; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Thromboxane-A Synthase

1997
Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    British journal of pharmacology, 2002, Volume: 137, Issue:7

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Aspirin; Blood Platelets; Chlorobenzenes; Cyclooxygenase Inhibitors; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rabbits; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes

2002